KYMR

Kymera Therapeutics (KYMR)

About Kymera Therapeutics (KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.

Details

Daily high

$80.00

Daily low

$77.08

Price at open

$77.56

52 Week High

$103.00

52 Week Low

$19.44

Market cap

6.3B

Dividend yield

0.00%

Volume

594,787

Avg. volume

726,614

P/E ratio

-22.13

Kymera Therapeutics News